Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "alexion pharmaceuticals"

Alexion Pharmaceuticals Moves Up In Market Cap Rank, Passing Norfolk Southern

Alexion Pharmaceuticals' (ALXN) CEO Leonard Bell on Q2 2014 Re...

Operator Good morning, and welcome to the Alexion Pharmaceuticals, Incorporated Second Quarter 2014 Results Conference Call. Today's call is being recorded. For opening remarks and introductions, I would like to turn the conference over to Mr. Seeking Alpha, 16 hours ago
Alexon raises earnings guidance after Q2 results Seeking Alpha, 21 hours ago

72 images for alexion pharmaceuticals

American Banking News, 1 day ago, 1 day ago, 1 day ago
American Banking News, 1 month ago
ETF Channel, 1 week ago
State Of The, 2 weeks ago
I Stock Analyst, 2 weeks ago
Daily Finance, 1 month ago
Waterbury Republican American, 1 month ago
Seeking Alpha, 1 month ago
American Banking News

Potential Alexion Pharmaceuticals (ALXN) Trade Has 9.18% Downside Protection

MarketIntelligenceCenter.comaEUR(TM)s patented algorithms have chosen the Nov. '14 $160.00 call for a couple of hedged-trading ideas on Alexion Pharmaceuticals Inc ("ALXN). A traditional covered ...
 Individual.com2 days ago Alexion Pharmaceuticals (ALXN) Showing Resistance Near $165.54  Individual.com3 days ago Alexion Pharmaceuticals (ALXN) Trading Near $154.72 Support Level  Individual.com1 week ago Zacks Downgrades Alexion Pharmaceuticals to Neutral (ALXN)  American Banking News2 weeks ago

Celgene, Alexion Beat Estimates, But Biotechs Fall

Big-cap biotechs Celgene and Alexion Pharmaceuticals modestly beat Q2 estimates and raised their guidance early Thursday, but their shares tumbled as Wall Street seemed to turn against the sector. Celgene 's (NASDAQ: CELG ) Q2 earnings rose 18% ...
 Investor's Business Daily16 hours ago Celgene, Alexion Earnings Top Street, But Stocks Fall  Investor's Business Daily21 hours ago Video: Celgene, Alexion Earnings Top, But Stocks Fall  Investor's Business Daily20 hours ago Biogen, Gilead Earnings Crush Q2 Estimates  Yahoo! Finance1 day ago

Alexion Pharmaceuticals Trading Lower on 1.5x Above-Average Volume (ALXN)

The price of Alexion Pharmaceuticals shares has slipped to $165.34 (a 4.5% change) on heavy trading volume. Today's volume of 2.0 million shares tops the average 30-day volume of 1.2 million shares. Unusually high volume can signify a potential ...
 Individual.com18 hours ago SmarTrend Watching for Potential Pullback in Shares of Alexion Pharmaceuticals After 1.31% Gain  Individual.com3 days ago Alexion Pharmaceuticals Falls 2.34% on Heavy Volume: Watch For Potential Rebound  Comtex SmarTrend1 week ago
American Banking News

Alexion Pharmaceuticals beats by $0.05, beats on revenue

06:36 ET | About: Alexion Pharmaceuticals, Inc. (ALXN) Alexion Pharmaceuticals (NASDAQ:ALXN): Q2 EPS of $1.12 beats by $0.05. Revenue of $512.49M (+38.5% Y/Y) beats
 Seeking Alpha1 day ago Alexion Pharmaceuticals EPS Estimates More Optimistic Over Past Month  Forbes.com1 day ago Alexion Pharmaceuticals (ALXN) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS  American Banking News22 hours ago Alexion Pharmaceutical To Beat Earnings Again  Bidness Etc2 days ago

Alexion Pharmaceuticals Q2 Earnings In Line;…

Alexion Pharmaceuticals ( ALXN - Analyst Report ) second-quarter 2014 earnings (including stock-based compensation expense) of 99 cents per share were in line with the Zacks Consensus Estimate. Increased costs led to modest results. Earnings were ...
 Zacks.com19 hours ago

Q2 2014 Alexion Pharmaceuticals Earnings Conference Call (Webcast)

The following audio is from a conference call that will begin on July 24, 2014 at 10:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Source: We cover over 5K calls/quarter You will now ...
 Seeking Alpha1 day ago

Today's Top Health Care Stocks: Alexion Pharmaceuticals, Bristol-Myers Squibb, Celgene Corp. and Eli

Let's take a look at today's top stories in biotech and health care. Keep an eye out for Alexion Pharmaceuticals ( NASDAQ: ALXN ) , Bristol-Myers Squibb ( NYSE: BMY ) , Celgene Corporation ( NASDAQ: CELG ) and Eli Lilly ( NYSE: LLY ) . ...
 Motley Fool1 day ago

Will Alexion Pharmaceuticals (ALXN) Miss This Earnings Season?

Unfortunately we are unable to process your request at this time. This error is usually temporary. Please try again later. If you continue to experience this error, it may be caused by one of the following: You may want to scan your system ...
 Yahoo! Finance1 day ago

Alexion Pharmaceuticals is Among the Companies in the Biotechnology Industry With the Highest P/E Ratio (ALXN, REGN, ACOR, CBST, PCYC)

(Comtex SmarTrend(R)) Below are the three companies in the Biotechnology industry with the highest price to earnings (P/E) ratios. P/E is an important valuation tool when comparing companies in the same industry. A higher P/E ratio means that ...
 Individual.com2 weeks ago Shares of Alkermes Rank the Lowest in Terms of Earnings Yield in the Biotechnology Industry (ALKS, LGND, ALXN, REGN, ACOR)  Comtex SmarTrend2 days ago Relatively Good Performance Detected in Shares of Exact Sciences in the Biotechnology Industry (EXAS, ITMN, ALXN, VRTX, RGEN)  Comtex SmarTrend2 weeks ago Gilead Sciences is Among the Companies in the Biotechnology Industry With the Highest Projected Earnings Growth (GILD, OSIR, LGND, ANIK, ALXN)  Comtex SmarTrend2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less